Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.85 |
| ▸ | CA6 | P23280 | 5/20 | 0.85 |
| ▸ | CA7 | P43166 | 5/20 | 0.85 |
| ▸ | CA9 | Q16790 | 5/20 | 0.85 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.85 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.85 |
| ▸ | CA2 | P00918 | 4/20 | 0.85 |
| ▸ | CA4 | P22748 | 4/20 | 0.85 |
| ▸ | CA5A | P35218 | 4/20 | 0.85 |
| ▸ | CA3 | P07451 | 3/20 | 0.85 |
| ▸ | MEN1 | O00255 | 2/20 | 0.83 |
| ▸ | RECQL | P46063 | 2/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.83 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.79 |
| ▸ | F13A1 | P00488 | 2/20 | 0.79 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.79 |
| ▸ | THPO | P40225 | 2/20 | 0.79 |
| ▸ | CASP2 | P42575 | 2/20 | 0.79 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6251707 | 0.96 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7712115 | 0.96 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| SCHEMBL6658738 | 0.96 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| Hydrochloric Acid SCHEMBL3673346 | 0.96 | UBE2N (0.80) | CA12CA6CA7CA9CA14 | |
| SCHEMBL11808474 | 0.93 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| Hydrochloric Acid SCHEMBL6250226 | 0.93 | UBE2N (0.75) | CA12CA6CA7CA9CA14 | |
| SCHEMBL9720429 | 0.93 | CA12 (0.79) | CA12CA6CA7CA9CA14 | |
| SCHEMBL17071917 | 0.93 | CA12 (0.93) | CA12CA6CA7CA9CA14 | |
| SCHEMBL817632 | 0.93 | — | — | |
| SCHEMBL345134 | 0.92 | CA12 (1.00) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200071566-A1 | SLURRY COMPOSITION FOR CHEMICAL MECHANICAL POLISHING | KCTECH CO., LTD. (KR) | 2020-03-05 | — | — | US | claimed |
| US-7695345-B2 | Polishing compound for semiconductor integrated circuit device, polishing method and method for producing semiconductor integrated circuit device | ASAHI GLASS COMPANY, LIMITED (JP) | 2010-04-13 | — | — | US | claimed |
| US-20250215264-A1 | SLURRY COMPOSITION FOR CHEMICAL MECHANICAL POLISHING, METHOD OF PREPARING SAME, AND CHEMICAL MECHANICAL POLISHING METHOD OF WAFER | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-07-03 | — | — | US | disclosed |
| US-20250043149-A1 | SLURRY COMPOSITION FOR CHEMICAL MECHANICAL POLISHING AND CHEMICAL MECHANICAL POLISHING APPARATUS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-02-06 | — | — | US | disclosed |
| US-11826485-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | HYPERBRANCH MEDICAL TECHNOLOGY, INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-10829690-B2 | Slurry composition for chemical mechanical polishing, method of preparing the same, and method of fabricating semiconductor device by using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-11-10 | — | — | US | disclosed |
| US-20200071566-A1 | SLURRY COMPOSITION FOR CHEMICAL MECHANICAL POLISHING | KCTECH CO., LTD. (KR) | 2020-03-05 | — | — | US | disclosed |
| US-20200071613-A1 | SLURRY COMPOSITION FOR CHEMICAL MECHANICAL POLISHING, METHOD OF PREPARING THE SAME, AND METHOD OF FABRICATING SEMICONDUCTOR DEVICE BY USING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-05 | — | — | US | disclosed |
| US-9803107-B2 | Polishing agent, polishing method and method for manufacturing semiconductor integrated circuit device | ASAHI GLASS COMPANY, LIMITED (JP) | 2017-10-31 | — | — | US | disclosed |
| EP-2734507-B1 | PROCESS FOR THE SYNTHESIS OF N-SUBSTITUTED CYCLIC ALKYLENE UREAS | ALLNEX IP S À R L (LU) | 2017-05-31 | — | — | EP | disclosed |
| US-9440928-B2 | Process for the synthesis of N-substituted cyclic alkylene ureas | Allnex IP S.ar.L. (LU) | 2016-09-13 | — | — | US | disclosed |
| EP-1160267-B1 | CATALYST FOR OXIDATIVE POLYMERIZATION OF FLUOROPHENOL, METHOD OF OXIDATIVE POLYMERIZATION OF FLUOROPHENOL, AND POLY(OXYFLUOROPHENYLENE) DERIVATIVE | JAPAN SCIENCE & TECH CORP (JP) | 2004-08-04 | — | — | EP | disclosed |
| US-6689919-B1 | SOLUBLE POLY(OXYFLUOROPHENYLENE) COMPOUNDS WITH EXCELLENT HEAT RESISTANCE, MEMBRANE-FORMABILITY AND CHEMICAL STABILITY | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2004-02-10 | — | — | US | disclosed |
| US-6673890-B1 | DETERGENTS, DISPERSANTS | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-06 | — | — | US | disclosed |
| EP-1198492-B1 | ZWITTERIONIC POLYAMINES AND A PROCESS FOR THEIR PRODUCTION | BASF AG (DE) | 2003-10-08 | — | — | EP | disclosed |
| US-5789418-A | Bis-naphthalimides for the treatment of cancer | BASF AKTIENGESELLSCHAFT (DE) | 1998-08-04 | — | — | US | disclosed |
| EP-0714387-B1 | NEW BIS-NAPHTHALIMIDES FOR THE TREATMENT OF CANCER | BASF AG (DE) | 1998-05-27 | — | — | EP | disclosed |
| EP-0042940-B1 | HETEROALKYLENE-BIS-ANTHRAQUINONES | AMERICAN CYANAMID COMPANY (US) | 1984-06-06 | — | — | EP | disclosed |
| EP-0042940-A1 | Heteroalkylene-bis-anthraquinones | AMERICAN CYANAMID COMPANY (US) | 1982-01-06 | — | — | EP | disclosed |
| US-4278605-A | ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11826485-B2 | Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices | PLOD3, LIG3, PLOD2 | CA12 2264/4885CA6 2865/4885CA7 2878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.